Trademark: 97127433
Status Date
Tuesday, July 11, 2023
Filing Date
Tuesday, November 16, 2021
Abandoned Date
Friday, June 9, 2023
5 The goods associated with our mark will be for internal and external wound care. We will use our direct internal delivery system of cannabinoids to be applied to the site of injury for open head neurotrauma wounds via our infused absorbable bandage. We will use direct internal delivery of cannabinoids to the site of injury for open spinal cord neurotrauma wounds via our infused absorbable bandage. We will use indirect delivery of cannabinoids to the brain for closed head neurotrauma wounds via nanoparticle delivery system; or by indirect delivery of cannabinoids to the brain for closed spinal cord neurotrauma wounds via nanoparticle delivery system; or by direct internal and external delivery systems of cannabinoids to dermal wounds for faster healing of subdermal and dermal skin layers
Jul 11, 2023
Abandonment Notice E-Mailed - Failure To Respond
Jul 11, 2023
Abandonment Notice Mailed - Failure To Respond
Jul 11, 2023
Abandonment - Failure To Respond Or Late Response
Mar 8, 2023
Notification Of Non-Final Action E-Mailed
Mar 8, 2023
Non-Final Action E-Mailed
Mar 8, 2023
Non-Final Action Written
Mar 1, 2023
Assigned To Examiner
Aug 29, 2022
Assigned To Examiner
Aug 26, 2022
Assigned To Examiner
Nov 23, 2021
New Application Office Supplied Data Entered
Trademark Alertz updated from USPTO on 2030-01-24